mFluor™ Blue 583 SE
Example protocol
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Mix 100 µL of a reaction buffer (e.g., 1 M sodium carbonate solution or 1 M phosphate buffer with pH ~9.0) with 900 µL of the target protein solution (e.g. antibody, protein concentration >2 mg/mL if possible) to give 1 mL protein labeling stock solution.
Note: The pH of the protein solution (Solution A) should be 8.5 ± 0.5. If the pH of the protein solution is lower than 8.0, adjust the pH to the range of 8.0-9.0 using 1 M sodium bicarbonate solution or 1 M pH 9.0 phosphate buffer.
Note: The protein should be dissolved in 1X phosphate buffered saline (PBS), pH 7.2-7.4. If the protein is dissolved in Tris or glycine buffer, it must be dialyzed against 1X PBS, pH 7.2-7.4, to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for protein precipitation.
Note: Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well. The presence of sodium azide or thimerosal might also interfere with the conjugation reaction. Sodium azide or thimerosal can be removed by dialysis or spin column for optimal labeling results.
Note: The conjugation efficiency is significantly reduced if the protein concentration is less than 2 mg/mL. For optimal labeling efficiency the final protein concentration range of 2-10 mg/mL is recommended.
Add anhydrous DMSO into the vial of mFluor™ Blue 583 SE to make a 10 mM stock solution. Mix well by pipetting or vortex.
Note: Prepare the dye stock solution (Solution B) before starting the conjugation. Use promptly. Extended storage of the dye stock solution may reduce the dye activity. Solution B can be stored in the freezer for two weeks when kept from light and moisture. Avoid freeze-thaw cycles.
SAMPLE EXPERIMENTAL PROTOCOL
This labeling protocol is specifically optimized for the conjugation of goat anti-mouse IgG with mFluor™ Blue 583 SE. Further optimization may be necessary for other proteins.
Note: Each protein requires a distinct dye/protein ratio, which also depends on the properties of dyes. Over-labeling of a protein could detrimentally affect its binding affinity, while the protein conjugates of low dye/protein ratio give reduced sensitivity.
Use a 10:1 molar ratio of Solution B (dye)/Solution A (protein) as the starting point. Add 5 µL of the dye stock solution (Solution B, assuming the dye stock solution is 10 mM) into the vial of the protein solution (95 µL of Solution A) with effective shaking. The concentration of the protein is ~0.05 mM assuming the protein concentration is 10 mg/mL and the molecular weight of the protein is ~200KD.
Note: We recommend using a 10:1 molar ratio of Solution B (dye)/Solution A (protein). If it is too low or too high, determine the optimal dye/protein ratio at 5:1, 15:1, and 20:1 respectively.
Continue to rotate or shake the reaction mixture at room temperature for 30-60 minutes.
The following protocol is an example of dye-protein conjugate purification by using a Sephadex G-25 column.
Prepare Sephadex G-25 column according to the manufacture instruction.
Load the reaction mixture (From "Run conjugation reaction") to the top of the Sephadex G-25 column.
Add PBS (pH 7.2-7.4) as soon as the sample runs just below the top resin surface.
Add more PBS (pH 7.2-7.4) to the desired sample to complete the column purification. Combine the fractions that contain the desired dye-protein conjugate.
Note: For immediate use, the dye-protein conjugate needs to be diluted with staining buffer, and aliquoted for multiple uses.
Note: For longer-term storage, the dye-protein conjugate solution needs to be concentrated or freeze-dried.
The Degree of Substitution (DOS) is the most important factor for characterizing dye-labeled protein. Proteins of lower DOS usually have weaker fluorescence intensity, but proteins of higher DOS (e.g., DOS > 6) tend to have reduced fluorescence too. The optimal DOS for most antibodies is recommended between 2 and 10, depending on the properties of dye and protein. For effective labeling, the degree of substitution should be controlled to have 6-8 moles of mFluor™ Blue 583 SE to one mole of antibody. The following steps are used to determine the DOS of mFluor™ Blue 583 SE labeled proteins.
To measure the absorption spectrum of a dye-protein conjugate, it is recommended to keep the sample concentration in the range of 1-10 µM depending on the extinction coefficient of the dye.
For most spectrophotometers, the sample (from the column fractions) needs to be diluted with de-ionized water so that the O.D. values are in the range of 0.1 to 0.9. The O.D. (absorbance) at 280 nm is the maximum absorption of protein, while 498 nm is the maximum absorption of mFluor™ Blue 583 SE. To obtain accurate DOS, ensure the conjugate is free of the non-conjugated dye.
You can calculate DOS using our tool by following this link: https://www.aatbio.com/tools/degree-of-labeling-calculator
Spectrum
Product family
Name | Excitation (nm) | Emission (nm) | Extinction coefficient (cm -1 M -1) | Correction Factor (260 nm) | Correction Factor (280 nm) |
mFluor™ Blue 570 SE | 553 | 565 | 1200001 | 0.228 | 0.179 |
mFluor™ Blue 630 SE | 470 | 632 | 490001 | 0.197 | 0.275 |
mFluor™ Blue 660 SE | 481 | 663 | 260001 | 0.338 | 0.32 |
mFluor™ Blue 580 SE | 485 | 580 | 400001 | 0.363 | 0.247 |
mFluor™ Blue 590 SE | 569 | 589 | 810001 | 0.671 | 0.406 |
mFluor™ Blue 620 SE | 589 | 616 | 980001 | 0.683 | 0.849 |
mFluor™ Blue 585 SE | 491 | 578 | 450001 | - | - |
mFluor™ Blue 615 SE | 510 | 615 | 400001 | - | - |
mFluor™ Blue 659 SE | 503 | 659 | 40000 | - | 0.162 |
References
Authors: Zöller, Katrin and Karlegger, Anna and Truszkowska, Martyna and Stengel, Daniel and Bernkop-Schnürch, Andreas
Journal: Journal of colloid and interface science (2024): 174-188
Authors: Raadsen, M and Langerak, T and Du Toit, J and Kruip, M J H A and Aynekulu Mersha, D and De Maat, M P M and Vermin, B and Van den Akker, J P C and Schmitz, K S and Bakhtiari, K and Meijers, J C M and van Gorp, E C M and Short, K R and Haagmans, B and de Vries, R D and Gommers, D A M P J and Endeman, H and Goeijenbier, M and ,
Journal: Journal of critical care (2024): 154463
Authors: Schofield, Craig J and Tirouvanziam, Rabindra and Garratt, Luke W
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology (2024)
Authors: Liu, Jie and Wang, Yan and Zhang, Suqin and Sun, Liyan and Shi, Yanmei
Journal: Placenta (2023): 50-57
Authors: Sui, Shuang and Zhang, Yanmei and Huang, Ying
Journal: Molecular and cellular endocrinology (2023): 111997